The matrix metalloproteinases play an important role in matrix degradation, but there is limited information about this family of enzymes in either normal or diseased human liver. In this study, we have examined the synthesis of a 72 kDa type IV collagenase/gelatinase by human hepatic lipocytes in primary culture. Hepatic lipocytes were isolated from wedges of normal human donor liver by Pronase/collagenase perfusion, purified by density-gradient centrifugation, and established in primary culture on uncoated plastic. By Northern-blot analysis, the total RNA extracted from cultured human lipocytes was found to contain 3.4 kb mRNA for the 72 kDa type IV collagenase/gelatinase. [14C]gelatin. The enzyme was released both in active and latent pro-enzyme forms and its inhibition profile was that of a metalloproteinase. These studies indicate that cultured human hepatic lipocytes express the gene for the 72 kDa type IV collagenase/gelatinase, and secrete this enzyme, particularly in prolonged primary culture. As this enzyme exhibits degradative activity against basement membrane collagen, its release by activated hepatic lipocytes in the space of Disse could lead to disruption of the normal subendothelial liver matrix. It is suggested that this enzyme may have an important role in human liver injury and fibrosis.
INTRODUCTION
Hepatic lipocytes (fat-storing or Ito cells) are mesenchymal liver cells, located in the subendothelial space of Disse. In normal liver, they contain multiple cytoplasmic vitamin A storage vacuoles and exhibit long stellate processes that encircle the hepatic sinusoid [1, 2] .
Current evidence points to lipocytes as the primary source of extracellular matrix in liver injury. In diseased human and animal liver, lipocytes proliferate in close morphological association with areas of injury and fibrosis [3] [4] [5] [6] [7] [8] [9] and adopt an activated or myofibroblast-like appearance [10] . In situ hybridization studies demonstrate that in animal models and human liver disease, mRNA transcripts for matrix proteins (collagens I and III) are confined exclusively to these cells [11] [12] [13] . These observations, suggesting an important role for activated lipocytes in liver fibrosis, have been supported by studies ofcultured lipocytes. Under conditions which promote activation (see below), lipocytes secrete collagens [14] , laminin [15] , proteoglycans [16, 17] and fibronectin [18] .
Identifying the stimuli which provoke lipocyte activation is a major focus ofcurrent studies. Although soluble factors including cytokines [19] [20] [21] [22] [23] and retinoids [24, 25] play a role, cell-matrix interactions may be equally important [26] . The normal subendothelial space of Disse contains a basement-membrane-like matrix comprised of type IV collagen [27, 28] , laminin [15] and proteoglycans [16] . When hepatic lipocytes are cultured on a model of this basement-membrane-like matrix (derived from the Engelbreth-Holm-Swarm murine sarcoma; EHS matrix) they are non-proliferative and synthesize small quantities of matrix proteins [26] . In contrast, cells grown on uncoated plastic or type I collagen become activated with the increasing duration of culture [26] . These studies imply that the normal liver matrix maintains hepatic lipocytes in a quiescent non-fibrogenic phenotype, and conversely, that disruption of this cell-matrix interaction is associated with development of a proliferative fibrogenic phenotype.
Differentiated functions of hepatocytes are also dependent on interactions with the normal liver matrix. When isolated hepatocytes are plated on basement-membrane-like matrices they maintain specific gene functions e.g. albumin or specific cytochrome P-450 isoenzyme expression, for prolonged periods [29] [30] [31] [32] . Cells cultured on type I collagen progressively de production. In an earlier study [33] [36] , transported and stored at 4°C, and used for lipocyte preparation within 48 h of removal, as previously described [36] .
In brief, a 400-600 g liver wedge was initially perfused at 60 ml/min with LI Lipocytes (>900% pure) were identified by phase-contrast microscopy ( Fig. 1) , and by endogenous vitamin A autofluorescence and expression of desmin as described previously [36] . The results presented in this paper originate from six different human lipocyte preparations.
Human gingival fibroblast preparation and culture Human gingival fibroblasts were prepared and maintained in culture as described by Heath et al. [39] . Before extraction of mRNA, cells were stimulated for 24 h with 3 % (w/v) partially purified cytokines [40] .
Preparation of cDNA for human 72 kDa type IV collagenase/gelatinase A 1.5 kb human 72 kDa type IV collagenase/gelatinase probe comprising nucleotides 76-1576 in the sequence described by Collier et al. [35] was obtained from a human gingival fibroblast cDNA library. The cDNA was generated from poly(A)+ RNA selected by oligo(dT)-cellulose chromatography after isolation of RNA by the guanidinium isothiocyanate/CsCl centrifugation method [41] from semi-confluent gingival fibroblasts that had been stimulated in DMEM/1 % fetal calf serum (FCS)/0.2 % lactalbumin hydrolysate/ 10 ng of phorbol myristate acetate (PMA)/ml and 3 % partially purified cytokines [40] for 24 h. cDNA synthesized using an Amersham kit was blunt-ended using T4 polymerase and then ligated to purpose-built oligonucleotide linkers. These linkers (12-mer and 16-mer), when annealed, resulted in a 3' overhang of 4 bp. The ligated cDNA was then loaded on to a 5-20% potassium acetate gradient (containing 10 lug of ethidium bromide/ml) and centrifuged at 100000 g for 20 h. Fractions, free of linkers and corresponding to > 1 kb in size, were pooled, concentrated by ethanol precipitation, and ligated to a modified SP64 vector (kindly provided by Dr. Spencer Emtage, Celltech Ltd., Slough, U.K.) that was cut with BstXl to produce a 5' overhang of 4 bp complementary to that generated by the cDNA-linker ligation. Recombined plasmids were diluted and transformed in library-efficient DH5 cells. Colony lifts on to Hybond-N were alkali-denatured, neutralized and fixed, followed by screening with an oligonucleotide probe corresponding to nucleotides 280-301 in the Collier et al. [35] sequence. Plasmid DNA was purified from positive clones and sequenced by the dideoxy-chain-termination method [42] [46] .
Quantitative analysis of gelatin-degrading activity. Human lipocyte media were dialysed against sample buffer (0.05 M-Tris, pH 7.6, 0.2 M-NaCl, 10 mM-CaCl2, 0.020 NaN3), for the quantitative assay of gelatin-degrading activity by the method of Harris & Krane [47] , with modifications as described previously [33] . Samples were assayed either non-activated or following activation with aminophenylmercuric acetate (APMA) (at a concentration of 1 mm for 60 min at 37 'C). For some experiments reactions were performed in the presence of proteinase inhibitors (as described in the Results section).
RESULTS

Detection of mRNA for type IV coliagenase/gelatinase
By Northern-blot analysis, total RNA from cultured human lipocytes was found to contain a single hybridization signal of 3.4 kb when probed with cDNA for 72 kDa type IV collagenase/ gelatinase (Fig. 2, lanes 2 and 3 and Fig. 3, lanes 1 and 2) . This signal was detectable after washing under stringent conditions (0.1 % SDS/0.1 x SSC at 70 'C), indicating that binding was specific. The estimated molecular size of 3.4 kb, corresponds to that previously reported for human 72 kDa type IV collagenase/ gelatinase mRNA in transformed human bronchial epithelial cells [35] , and is identical in size to the mRNA detected in stimulated human gingival fibroblasts using the same cDNA probe (Fig. 2, lane 1) . In total RNA prepared from freshly isolated human lipocytes, mRNA for 72 kDa type IV collagenase/gelatinase was barely detectable (Fig. 3 ), but the concentration had increased markedly, in the same lipocyte preparation, by day 12 in primary culture (Fig. 3) Release of type IV coliagenase/gelatinase activity by human lipocytes (a) Zymography. When analysed by gelatin zymography, media from human hepatic lipocytes contained a single band of gelatin-degrading activity, of molecular mass 65 kDa (Fig. 6 ). This co-migrated with a well-characterized major band of gelatindegrading activity released by cultured rat hepatic lipocytes [33] (Fig. 6) . No gelatin-degrading activity was detected in cell-free blank control media and release of the activity of the 65 kDa protein was markedly inhibited by incubation of lipocyte cultures in media containing cycloheximide at a concentration of 5 /tg/ml (Fig. 6) 10 mM-CaCI2 and 0.02% azide. Gelatin-degrading activity was assayed using heat-denatured (60°C, 20 min) rat skin "C-labelled type I collagen as the substrate (specific radioactivity 377 c.p.m./,ug) as described in the Materials and methods section, with or without activation (1 mM-APMA for 60 min at 37°C). For some experiments proteinase inhibitors were added to APMAactivated samples as shown. Percentage activity results (*) for PMSF-treated samples were calculated by comparison with the appropriate solvent control (propan-2-ol). One m-unit of gelatinase activity was defined as degradation of 1 ng of gelatin/min. The measured radioactivity averaged 2122 c.p.m. for non-activated and 4424 c.p.m. for APMA-activated samples. Abbreviation: NEM, Nethylmaleimide. Table 1 ).
DISCUSSION
The family of matrix metalloproteinases consists of at least eight closely related genes which encode for enzymes involved in degradation of matrix proteins [48, 49] . Type IV collagenase/ gelatinase (72 kDa) is one member of this family of enzymes, which exhibits degradative activity against type IV and denatured collagens and is secreted by cells of mesenchymal origin [33, 34] and by transformed [35] or neoplastic cells [50] .
In liver, the role of metalloproteinases in normal matrix turnover or pathological fibrosis is uncertain. The types of metalloproteinases secreted, their cellular origins and relative activities are poorly defined [51] . Thus little is known about metalloproteinase gene expression and its regulation in liver. We have reported previously the release of 72 kDa type IV collagenase/gelatinase by purified rat hepatic lipocytes [33] . Extension of these observations in rat tissue to man has been made possible by our [14, 26, 37, 52] . Our studies suggest that this well-characterized phenotypic activation is also associated with expression of the gene for 72 kDa type IV 1 1 collagenase/gelatinase in cultured human lipocytes. In addition to contact with plastic, lipocyte activation may occur in these cultures because of exposure to cytokines, which promote lipocyte proliferation via induction of platelet-derived growth factor (PDGF) receptor expression [19] . Other cytokines, e.g. transforming growth factor-fl (TGF-fl) [53] , may also be involved in modulating type IV collagenase/gelatinase gene expression in hepatic lipocytes. The relative importance of these stimulatory cytokines in vivo has yet to be determined.
These studies of gene expression were complemented by immunolocalization and immunoprecipitation studies demonstrating that cultured human lipocytes synthesize and secrete 72 kDa type IV collagenase/gelatinase. In 6 ). Secondly, degradative activity was also demonstrated against soluble [14C]gelatin. Although detectable in untreated samples, the activity was markedly increased following activation with APMA, indicating that the type IV collagenase/gelatinase was released predominantly in the proenzyme form. The mechanism of activation of this enzyme in vivo is currently unknown. The APMA-activated enzyme was completely inhibited by EDTA, but not by thiol or serine proteinase inhibitors. Together these results indicate that the gelatin-degrading enzyme released by cultured human lipocytes is a metalloproteinase with properties identical to those previously reported for 72 kDa type IV collagenase/gelatinase [34, 35] .
The physiological role of 72 kDa type IV collagenase/ gelatinase is uncertain. In normal liver our results indicate that expression of this gene by lipocytes is low, consistent with minimal turnover of the extracellular matrix. This low level of expression may reflect a 'housekeeping' function for lipocytes in matrix remodelling in the space of Disse. The proenzyme form of 72 kDa type IV collagenase/gelatinase is also a normal component of human plasma [54] ; however, the significance of this observation is unclear. It seems more likely that the enzyme's activities are most significant within local tissues rather than as a systemic mediator, particularly during inflammation and repair. The effects of the active enzyme include disruption of basement membranes, leading to secondary effects on cell function. In diseased liver, secretion of this enzyme by activated lipocytes may be particularly important as the normal subendothelial matrix, comprising of type IV collagen, proteoglycans and laminin, maintains differentiated functions of hepatocytes [29] [30] [31] [32] and also maintains hepatic lipocytes in a quiescent non-fibrogenic phenotype [26] . Degradation of the normal liver matrix may disturb hepatocyte function and further promote activation of lipocytes to a proliferating and fibrogenic phenotype. The ability to degrade normal subendothelial matrix may also facilitate migration of lipocytes through the space of Disse to sites of liver injury. It is suggested that secretion of 72 kDa type IV collagenase/gelatinase by activated hepatic lipocytes may contribute significantly to the pathogenesis of liver fibrosis in man.
